CDNA News

Latest breaking news and updates for CDNA stock.

Track all markets on TradingView

Saxena White P.A. and Robbins Geller Rudman & Dowd LLP Announce a Proposed Settlement in the CareDx, Inc., Securities Litigation

SAN FRANCISCO, Aug. 14, 2025 /PRNewswire/ -- UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN FRANCISCO DIVISION PLUMBERS & PIPEFITTERS LOCAL UNION #295 PENSION FUND, Individually a...

What are the broader implications for CareDx’s competitive positioning if the settlement alters its R&D or commercialization plans? How might the settlement influence analyst coverage and earnings guidance revisions for CareDx? Are there any changes in insider holdings or recent insider trading activity surrounding the announcement?
Lawsuits
11 days ago
Read more prnewswire

CareDx Announces Appointment of Nathan Smith as Chief Financial Officer

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clin...

Could the CFO transition lead to revisions in the company's financial reporting cadence or transparency? Is there any anticipated impact on the company's credit facilities or debt repayment plans with the new CFO in place? How does this appointment compare to recent CFO changes in peer companies within the transplant/precision medicine space?
Leadership
18 days ago
Read more businesswire

CareDx Announces Second Quarter 2025 Financial Results

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company - a leading precision medicine company focused on the discovery, development and commercialization of clinica...

Are there any changes to the capital‑return policy (share repurchases or dividends) that could impact investor sentiment? What is the cash balance and burn rate post‑quarter, and does the company have adequate liquidity to fund its growth initiatives? How has the market reacted to the release so far, and what volume and price trends are emerging in real‑time trading?
Earnings
19 days ago
Read more businesswire

CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clin...

How might the KOAR study influence investor sentiment ahead of upcoming earnings releases or conference presentations? Will the KOAR results lead to updates in guidance or recommendations from transplant societies, potentially increasing adoption rates? What is the anticipated impact of the KOAR study on CareDx's earnings forecasts for the next 12‑24 months?
Clinical trials
19 days ago
Read more businesswire